Embryonic Steroids Control Developmental Programming of Energy Balance

Area of Science:

• Endocrinology
• Developmental Biology
• Metabolic Regulation

Background:

• Neonates transition from maternal energy supply to endogenous glucose production at birth.
• The precise mechanisms governing this metabolic shift, particularly the role of steroids, remain unclear.
• Steroids are vital signaling molecules with diverse physiological roles.

Purpose of the Study:

• To investigate the role of de novo steroid synthesis in fetal energy homeostasis.
• To elucidate the impact of impaired steroidogenesis on glucose metabolism and insulin function in utero.
• To determine if fetal steroids regulate key genes involved in energy production and storage.

Main Methods:

• Utilized a mouse model with a disrupted Cyp11a1 gene, preventing de novo steroid synthesis.
• Analyzed fetal development, focusing on blood glucose, insulin levels, and liver glycogen stores.
• Examined the expression of genes related to gluconeogenesis and glycogenesis.
• Assessed the effects of maternal glucocorticoid supplementation on mutant embryos.

Main Results:

• Cyp11a1 null embryos exhibited reduced blood glucose, impaired insulin secretion, and deficient liver glycogen storage.
• Expression of hepatic gluconeogenic and glycogenic genes was significantly decreased in mutant fetuses.
• Maternal glucocorticoids partially rescued blood glucose and glycogen levels but did not restore gene expression for glycogen synthesis, highlighting the necessity of fetal steroid production.

Conclusions:

• Fetal energy homeostasis is established prenatally, requiring endogenous steroid synthesis.
• Fetal steroids are essential for regulating glycogen synthesis, hepatic gluconeogenesis, and insulin secretion.
• Disruption of steroidogenesis leads to significant metabolic defects during fetal development.